Vacuumtherapy After Venous Hybrid Procedures

Maastricht University Medical Center40 enrolled

Overview

All patients with deep venous obstruction below the sapheno-femoral junction elective for hybrid procedure with creation of an arterio venous-fistula (AVF) in the MUMC or patients with primary percutaneous procedure (and thus venous obstruction above the sapheno-femoral junction) who present with occluded stents which need an additional AVF after thrombolysis will receive a Prevena NPWT. Incidence of wound infections and wound scoring will be performed afterwards.

Study Type

INTERVENTIONAL

Allocation

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Wound Infection

Interventions

Prevena, KCI, Acelity, NPWTDEVICE

All patients will receive a Prevena NPWT (if inclusion criteria are met)

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * All patients with deep venous obstruction below the sapheno-femoral junction primary elective for hybrid procedure with creation of an AV-fistula in the MUMC * Be able to communicate in Dutch * Life expectancy \>1 year Exclusion Criteria: * Patients with allergies for the components of the used negative pressure incision management system (Prevena)

Locations (1)

Maastricht University Medical Centre

Maastricht, Limburg, Netherlands

RECRUITING

Outcomes

Primary Outcomes

Number of Patients With wound infections or Adverse Events That Are Related to Prevena incision management negative pressure wound therapy

Patients will be prospectively followed and checked for development of wound infections (grade 1-5). Therapy to treat the infections will be monitored.

Time frame: 3 months

Central Contacts

Timme van Vuuren, MD

CONTACT

timme.van.vuuren@mumc.nl

J. van Laanen, MD

CONTACT

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.